Get the Stockscreener App
2.15
1.83%
-0.04
After Hours:
2.14
-0.010
-0.47%
Ambev S A Adr Stock (ABEV) Latest News
The Best Defensive Stocks to Buy - Morningstar
Earnings call: Ambev reports solid growth and profitability in Q3 2024 - Investing.com India
Ambev SA Stock Price Remains Flat; Morningstar Suggests Fair Value at $3.23 - TopNews India
Ambev - TopNews India
Thinking Of Investing In Ambev S.A. ADR (NYSE: ABEV) Stock? Read This First - Stocks Register
Ambev SA earnings missed, revenue fell short of estimates - Investing.com
Want Safe Dividend Income in 2024 and Beyond? Invest in the Following 3 Ultra-High-Yield Stocks. - The Motley Fool
ABEV (Ambev S.A. ADR) may reap gains as insiders became active recently - Knox Daily
Daily Progress: Ambev S.A. ADR (ABEV) Drop -2.56, Closing at 2.28 - The Dwinnex
Ambev S.A. ADR (ABEV) Stock: The Story of a 52-Week Stock Range - The InvestChronicle
Ambev: A Quintessential Value Stock With Low Multiples And Strong Financials (NYSE:ABEV) - Seeking Alpha
Ambev S.A. ADR (ABEV) is looking forward to a strong quarter - SETE News
What to expect from Ambev S.A. ADR’s (ABEV) current quarter earnings? - US Post News
Post-Trade Analysis: Ambev S.A. ADR (ABEV) Slides -1.66, Closing at 2.37 - The Dwinnex
Understanding the Risks of Investing in Ambev S.A. ADR (ABEV) - Knox Daily
ABEV Stock: Exploring Ambev S.A. ADR’s Growth - The InvestChronicle
The New York Stock Exchange | NYSE - NYSE
A Tale of Resilience: Ambev S.A. ADR Amid Stock Market Turbulence - The InvestChronicle
ABEV’s Q2 earnings estimates: What investors need to know - US Post News
Sea Limited Sponsored ADR (SE) Stock Moves -0.17%: What You Should Know - MSN
Anheuser-Busch InBev S.A. ADR outperforms market despite losses on the day - MSN
Anheuser-Busch InBev SA/NV (BUD) Stock Price, News, Quote & History - Yahoo Finance
Ambev S.A. (ABEV) Stock Price, News, Quote & History - Yahoo Finance
RLX Technology Inc ADR (RLX) Volatility Hits 8.76%: What Good Investors Need To Be Aware Of - Stocks Register
KE Holdings Inc ADR’s (BEKE) Stock Is Harder To Predict Than You Think - Stocks Register
Ambev S.A. ADR (ABEV) Has Recovered 21.48% From Its Low: Is This The Beginning Of A Trend? - Stocks Register
Virgin Galactic Holdings Inc (SPCE) With A Potential Upside Of More Than -696.02% - Stocks Register
Barclays Downgrades Ambev S.A. ADR (ABEV) to an Equal weight from an Overweight - Knox Daily
8X8 Inc. [EGHT] Insider Activity: An Update for Investors - Knox Daily
Honest Company Inc [HNST] Investment Appeal on the Rise - Knox Daily
Analyzing Roblox Corporation (RBLX) After Recent Trading Activity - Knox Daily
Recent Insider Activity Could Benefit Regenxbio Inc (RGNX) - Knox Daily
Barclays slashes price target on Ambev S.A. ADR [ABEV] – find out why. - The DBT News
Are Finance Stocks Lagging Axa (AXAHY) This Year? - Yahoo Finance
Ambev S.A. ADR (ABEV) Stock: 52-Week Performance Insights and Trading Volume - The InvestChronicle
A closer look at ABEV’s price-to-free cash flow ratio - US Post News
Ambev S.A. ADR (ABEV) Stock Behavior Is Not Predictable - Stocks Register
Anheuser-Busch InBev S.A. ADR underperforms Monday when compared to competitors - MarketWatch
ABEV’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle
Anheuser-Busch InBev SA/NV (NYSE:BUD) Shares Sold by Davidson Kempner Capital Management LP - Defense World
Anheuser-Busch InBev SA/NV (NYSE:BUD) Shares Bought by Heron Bay Capital Management - Defense World
Anheuser-Busch InBev SA/NV (NYSE:BUD) Shares Bought by Callan Capital LLC - Defense World
Anheuser-Busch InBev SA/NV (NYSE:BUD) Stake Increased by Moors & Cabot Inc. - Defense World
DekaBank Deutsche Girozentrale Makes New $1.08 Million Investment in Anheuser-Busch InBev SA/NV (NYSE:BUD) - MarketBeat
Anheuser-Busch InBev S.A. ADR rises Thursday, still underperforms market - MSN
Capco Asset Management LLC Buys 7,193 Shares of Anheuser-Busch InBev SA/NV (NYSE:BUD) - Defense World
ABEV Stock: A Comprehensive Analysis and Forecast - The InvestChronicle
ABEV’s Stock Market Pendulum: Swinging Between Gains and Losses - The InvestChronicle
Recursion Pharmaceuticals Inc (NASDAQ: RXRX) Up 0.78%: This Is What Analysts Are Now Forecasting - Stocks Register
Nothing is Better Than Ambev S.A. ADR (ABEV) stock at the moment - SETE News
How does ABEV’s price to cash per share ratio compare in the market? - US Post News
The ABEV Stock Puzzle: Unraveling Ambev S.A. ADR’s Fluctuating Performance - The InvestChronicle
Barclays lifts Ambev S.A. ADR [ABEV] price estimate. Who else is bullish? - The DBT News
What to expect from ABEV’s earnings report this quarter? - US Post News
Weekly Upgrades and Downgrades - InvestorPlace
Does Ambev S.A. ADR (NYSE: ABEV) Still Need To Convince Analysts? - Stocks Register
Ambev S.A. ADR [ABEV] fell -18.93% so far this year. What now? - The DBT News
Ambev S.A. ADR (ABEV) Stock: A Year of Market Fluctuations - The InvestChronicle
Get in on Ambev S.A. ADR’s (ABEV) buy-in window today! - SETE News
The 10 Best Companies to Invest in Now - Morningstar
ABEV stock’s current quarter earnings estimates: What analysts predict? - US Post News
A better buy-in window may exist right now for Ambev S.A. ADR (ABEV) - SETE News
Closing Bell Recap: Ambev S.A. ADR (ABEV) Ends at 2.33, Reflecting a -1.27 Downturn - The Dwinnex
Right Now, Here’s How You Can Trade Ambev S.A. ADR (ABEV) Aggressively - US Post News
ABEV: Riding the Market Waves of Growth and Decline in 2023 - The InvestChronicle
Ambev S.A. ADR [ABEV] Stock trading around $2.39 per share: What’s Next? - The DBT News
2.01%
1.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):